Quick Answer
SELLAS Life Sciences Group, Inc. reported Stockholders Equity of $70.87 million for the year ending 2025.
- SELLAS Life Sciences Group, Inc. showed an increase of +648.8% in Stockholders Equity from 2024 to 2025.
- This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2011: $9.86 million | Q3 2011: $4.71 million | Q1 2012: -$10.57 million | Q2 2012: $19.12 million | Q3 2012: $14.17 million | Q1 2013: $23.31 million | Q2 2013: $15.23 million | Q3 2013: $34.62 million | Q1 2014: $46.50 million | Q2 2014: $28.31 million | Q3 2014: $30.86 million | Q1 2015: $59.08 million | Q2 2015: $49.37 million | Q3 2015: $32.42 million | Q1 2016: $12.41 million | Q2 2016: $20.32 million | Q3 2016: $23.93 million | Q1 2017: $27.19 million | Q2 2017: $19.13 million | Q3 2017: $14.64 million | Q1 2018: -$1.32 million | Q2 2018: -$2.48 million | Q3 2018: $18.46 million | Q1 2019: $2.95 million | Q2 2019: $14.34 million | Q3 2019: $10.64 million | Q1 2020: $8.06 million | Q2 2020: $3.78 million | Q3 2020: $7.95 million | Q1 2021: $28.74 million | Q2 2021: $33.42 million | Q3 2021: $26.61 million | Q1 2022: $4.03 million | Q2 2022: $19.06 million | Q3 2022: $12.60 million | Q1 2023: $13.17 million | Q2 2023: $4.84 million | Q3 2023: -$3.83 million | Q1 2024: $9.68 million | Q2 2024: $2.91 million | Q3 2024: $15.89 million | Q1 2025: $27.76 million | Q2 2025: $26.15 million | Q3 2025: $45.63 million.
- Over the full 16 years of available data (2010 to 2025), SELLAS Life Sciences Group, Inc.'s Stockholders Equity has grown by 2,816.5%.
- Historical annual values: Fiscal year 2025: $70.87 million | Fiscal year 2024: $9.47 million | Fiscal year 2023: -$7.98 million | Fiscal year 2022: $4.85 million | Fiscal year 2021: $20.35 million | Fiscal year 2020: $27.96 million | Fiscal year 2019: $6.09 million | Fiscal year 2018: $5.25 million | Fiscal year 2017: $2.07 million | Fiscal year 2016: -$5.00 million | Fiscal year 2015: -$12.26 million | Fiscal year 2014: $37.06 million | Fiscal year 2013: $5.89 million | Fiscal year 2012: $27.76 million | Fiscal year 2011: $10.11 million | Fiscal year 2010: $2.43 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: